


Viome Life Sciences Revenue
Wellness and Fitness Services • Bellevue, Washington, United States • 21-50 Employees
Viome Life Sciences revenue & valuation
| Annual revenue | $4,111,111 |
| Revenue per employee | $172,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Wellness and Fitness Services industry and current estimated revenues | $13,200,000 |
| Total funding | No funding |
Key Contacts at Viome Life Sciences
Naveen Jain
Founder & Ceo
Lan Hu
Director, Data Science And Bioinformatics
Anel Visser
Senior Clinical Operations Director At At Viome Life Sciences
Company overview
| Headquarters | 205 108th Ave NE, Bellevue, Washington 98004, US |
| Phone number | +18559584663 |
| Websites | |
| NAICS | 71394 |
| Keywords | Life Sciences, Health Sciences, RNA, Artificial Intelligence, Therapeutics, Microbiome, Chronic Diseases, Mrna, Metatranscriptomics, Human Gene Expression, Microbial Gene Expression |
| Founded | 2016 |
| Employees | 21-50 |
| Socials |
Viome Life Sciences Email Formats
Viome Life Sciences uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@viome.com), used 44.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@viome.com | 44.8% |
{first name}.{last name} | john.doe@viome.com | 34.5% |
{first name} | john@viome.com | 20.7% |
About Viome Life Sciences
Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting and preventing chronic diseases, cancers, and aging through a deeper understanding of an individual's biology at a molecular level. Viome's Consumer Services (VIOME) provides the industry's only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need. Our Health Sciences division focuses on key initiatives including prediction, early diagnostics, prognostics, and precision therapeutics to help people live a disease free life. With our state of the art artificial intelligence platform, we are able to analyze data from the world's largest and richest gene expression database in order to identify the root causes of chronic diseases, cancers, and aging and the mechanisms of action to be able to prevent and reverse them. Prediction: Using advanced AI methods to discover host/microbial biomarkers that predict the risk of developing severe chronic conditions, including cancers. Early Diagnostics: Using host/microbial biomarkers to diagnose severe chronic conditions including cancers at the earliest possible stage. Early diagnosis will enable earlier treatment which often is associated with higher efficacy. Prognostics: Leveraging host/microbial biomarkers to develop companion diagnostics to predict drug effectiveness and further improve responsiveness of patients by proposing AI-guided modulation of the microbiome. Therapeutics: By targeting the root cause of specific chronic diseases with prophylactics or therapeutics such as drugs, monoclonal antibodies, vaccines, phages, or other appropriate modalities.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Viome Life Sciences has 13 employees across 8 departments.
Departments
Number of employees
Viome Life Sciences Tech Stack
Discover the technologies and tools that power Viome Life Sciences's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
PaaS
Issue trackers
JavaScript frameworks
Tag managers
CMS
Programming languages
Security
Miscellaneous
JavaScript frameworks
JavaScript libraries
Miscellaneous
Frequently asked questions
4.8
40,000 users



